Flagship Pioneering (fka Flagship Ventures), a Cambridge, MA-based life sciences venture capital firm, is seeking to raise $500m for its latest fund.
Congressional lawmakers from both parties have rejected the Trump administration’s proposals to cut spending for NIH, and have joined forces to increase spending on biomedical research.
Developers Taconic Investment Partners and Silverstein Properties are spending $20 million to renovate the 326,861-sf Movie Lab building in Midtown Manhattan for life science research usage.
After holding it in the District for years, the health system is packing up and taking its annual symposium across the country.
Emergent Biosolutions produces cures in Downtown Baltimore for cancer patients, troops and stockpiles in case of a chemical attack.
Fractal Technology, a startup founded at Johns Hopkins, was recently acquired by Annapolis Junction–based Sunayu, according to the cofounders.
Threats come in all sizes, some so small you can’t see. The damage, however can be catastrophic.
Emergent BioSolutions creates remedies for diseases like cancer and ebola, chemical attacks like anthrax, as well as those against our troops, like mustard gas.
The Johns Hopkins University and the University of Maryland, College Park were ranked among the top tier in the U.S. News and World Report annual rankings of colleges and universities released Tuesday.
UK-based liquid biopsy firm Angle said today that it has inked a comarketing agreement with Qiagen for circulating tumor cell (CTC) technology.
What does it really cost to bring a drug to market?
The question is central to the debate over rising health care costs and appropriate drug pricing. President Trump campaigned on promises to lower the costs of drugs.